Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review

The Infusion Center

In: The Comprehensive Cancer Center: Development, Integration, and Implementation [Internet]. Cham (CH): Springer; 2022. Chapter 5.
.
Affiliations
Review

The Infusion Center

Mohamed A. Kharfan-Dabaja.

Excerpt

Availability of more effective supportive therapies coupled with emergence of novel antineoplastic agents has facilitated administration of cancer treatments outside the hospital setting. Cancer treatments typically require multiple visits. Accordingly, it can be exhausting for patients and their caregivers who are already under a lot of stress including physical, emotional and financial strain, among others. Infusion centers allow providers to help patients better manage and control their disease and associated symptoms by providing a continuity of care throughout their medical need, enhancing continuity of care and improving compliance. Here, we described the major components required for successful operation of a cancer infusion center. The ultimate goal is to offer a patient-centered experience that improves the overall quality of delivered care at a sustainable cost.

PubMed Disclaimer

References

    1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30. - PubMed
    1. Herbrecht R, et al. Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med. 2002;347(6):408–15. - PubMed
    1. Navari RM, Aapro M. Antiemetic prophylaxis for chemotherapy-induced nausea and vomiting. N Engl J Med. 2016;374(14):1356–67. - PubMed
    1. Bennett CL, et al. Colony-stimulating factors for febrile neutropenia during cancer therapy. N Engl J Med. 2013;368(12):1131–9. - PMC - PubMed
    1. Schmid P, et al. Pembrolizumab for early triple-negative breast cancer. N Engl J Med. 2020;382(9):810–21. - PubMed